Healthequity Inc (NASDAQ:HQY) VP Darcy G. Mott sold 9,500 shares of the stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $55.19, for a total value of $524,305.00. Following the completion of the transaction, the vice president now owns 102,500 shares in the company, valued at $5,656,975. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
Healthequity Inc (HQY) traded down $5.97 during trading hours on Thursday, hitting $50.74. The stock had a trading volume of 1,270,000 shares, compared to its average volume of 562,308. Healthequity Inc has a 1-year low of $37.62 and a 1-year high of $57.72. The company has a market cap of $3,080.00, a price-to-earnings ratio of 68.57, a P/E/G ratio of 2.13 and a beta of 1.70.
Healthequity (NASDAQ:HQY) last posted its quarterly earnings results on Tuesday, December 5th. The company reported $0.17 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.13 by $0.04. Healthequity had a return on equity of 14.47% and a net margin of 21.08%. The business had revenue of $56.80 million for the quarter, compared to analyst estimates of $55.27 million. During the same period last year, the company earned $0.10 EPS. The firm’s revenue was up 31.0% on a year-over-year basis. equities analysts predict that Healthequity Inc will post 0.73 EPS for the current year.
HQY has been the topic of a number of recent research reports. Zacks Investment Research lowered Healthequity from a “buy” rating to a “hold” rating in a research report on Wednesday, November 15th. BidaskClub upgraded Healthequity from a “sell” rating to a “hold” rating in a research report on Friday, December 22nd. Citigroup began coverage on Healthequity in a research report on Thursday, January 4th. They issued a “buy” rating on the stock. Chardan Capital raised their price target on Healthequity from $58.00 to $62.00 and gave the stock a “buy” rating in a research report on Wednesday, December 6th. Finally, Cantor Fitzgerald restated a “buy” rating and issued a $56.00 price target on shares of Healthequity in a research report on Tuesday, December 5th. One equities research analyst has rated the stock with a hold rating and ten have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $56.67.
A number of institutional investors have recently modified their holdings of HQY. Zions Bancorporation acquired a new stake in Healthequity during the 3rd quarter worth $119,000. Catalyst Capital Advisors LLC acquired a new stake in Healthequity during the 4th quarter worth $149,000. CIBC Asset Management Inc acquired a new stake in Healthequity during the 3rd quarter worth $208,000. Two Sigma Securities LLC acquired a new stake in Healthequity during the 4th quarter worth $208,000. Finally, Ameritas Investment Partners Inc. raised its stake in Healthequity by 17.4% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 4,375 shares of the company’s stock worth $218,000 after buying an additional 648 shares during the period. 99.47% of the stock is currently owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY WARNING: “Darcy G. Mott Sells 9,500 Shares of Healthequity Inc (HQY) Stock” was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this story on another site, it was illegally stolen and reposted in violation of United States & international copyright laws. The legal version of this story can be accessed at https://www.dispatchtribunal.com/2018/02/22/darcy-g-mott-sells-9500-shares-of-healthequity-inc-hqy-stock.html.
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.